Conclusions: Our data demonstrates that PTs with STEMI and a CTO have higher inhospital, 30 day, and one year mortalities than STEMI PTs without a CTO. PTs with NSTEACS and a CTO have higher in-hospital and 30 day mortality than NSTEACS PTs without a CTO, and there is a non-significant trend towards increased one year mortality for PTs with a CTO. Strategies to reduce this increased mortality are needed. Background: Cardiac arrest (CA) is often the result of both acute and chronic coronary artery disease (CAD) particularly when it is caused by ventricular tachycardia or fibrillation (VT/VF). Therapeutic hypothermia has been shown to decrease mortality and after resuscitated CA (rCA). It has been demonstrated that a chronic total occlusion (CTO) in the non-infarct artery in patients (Pts) with ST segment elevation myocardial infarction (STEMI) is associated with increased mortality. The incidence and effect of CTOs in Pts with rCA has not been well described. Further the incidence and effect of CTOs in rCA Pts as the result of STEMI is unknown. Methods: The Minneapolis Heart Institute has developed formalized protocols for both STEMI (Level One, L1) and cardiac arrest and sequential therapeutic hypothermia (CoolIt). From 2006-May 2012, 164 sequential Pts who had been enrolled in the Cool-It program who presented with VT/VF and underwent angiography were evaluated for the presence of at least one CTO in a major coronary vessel. From 2006-May 2012, 121 PTs who had been enrolled in the Cool-It program and underwent angiography but also suffered from STEMI were also evaluated for CTOs. In-hospital, 30 day, and 1 year mortality were compared between Pts who did and did not have CTO. STEMI Pts who presented with rCA were compared to STEMI Pts without rCA for the presence of a CTO.
Background: Cardiac arrest (CA) is often the result of both acute and chronic coronary artery disease (CAD) particularly when it is caused by ventricular tachycardia or fibrillation (VT/VF). Therapeutic hypothermia has been shown to decrease mortality and after resuscitated CA (rCA). It has been demonstrated that a chronic total occlusion (CTO) in the non-infarct artery in patients (Pts) with ST segment elevation myocardial infarction (STEMI) is associated with increased mortality. The incidence and effect of CTOs in Pts with rCA has not been well described. Further the incidence and effect of CTOs in rCA Pts as the result of STEMI is unknown. Methods: The Minneapolis Heart Institute has developed formalized protocols for both STEMI (Level One, L1) and cardiac arrest and sequential therapeutic hypothermia (CoolIt) . From 2006 -May 2012 sequential Pts who had been enrolled in the Cool-It program who presented with VT/VF and underwent angiography were evaluated for the presence of at least one CTO in a major coronary vessel. From 2006 -May 2012 PTs who had been enrolled in the Cool-It program and underwent angiography but also suffered from STEMI were also evaluated for CTOs. In-hospital, 30 day, and 1 year mortality were compared between Pts who did and did not have CTO. STEMI Pts who presented with rCA were compared to STEMI Pts without rCA for the presence of a CTO.
Results: See table below:
Conclusions: These data demonstrate that rCA Pts presenting with VT/VF and who have a CTO appear to have similar mortality compared to those without a CTO. Pts with and without a CTO who presented with rCA and STEMI have similar mortality although there is a trend in favor of those without a CTO. STEMI Pts with rCA have a higher incidence of a CTO than do STEMI Pts without rCA. Further efforts to understand, treat, and avoid CA in Pts with a CTO are warranted.
TCT-372
"Full metal jacket" (stented length > or [ 50 mm) using drug-eluting stents for chronic total occlusive lesions. Background: Limited data exists on patients who have undergone drug eluting stent (DES) implantation of long chronic total occlusive (CTO) lesion in native coronary arteries. Methods: We defined long continuous stent implantation (stent length > or ¼ 50 mm) as "full metal jacket" (FMJ). From April 2007 to March 2013, 344 consecutive patients (361 lesions) who underwent FMJ using any DESs for de novo lesion were enrolled. Subjects were classified into two groups: the patients with CTO lesion (CTO group, 113 patients, 114 lesions) and without CTO lesion (non-CTO group, 239 patients, 247 lesions). The two groups were compared for mean 24AE19 months clinical outcomes. Endpoints were freedom from target lesion revascularization (TLR) and major adverse cardiovascular events (MACE) defined as composite of TLR, myocardial infarction and all cause death at 5 years after percutaneous coronary intervention procedure. This was a single center non-randomized retrospective study. Background: The use of retrograde approach for recanalization of chronic total occlusion (CTO) has been established with improved success rates. During the procedure of percutaneous coronary intervention (PCI) for CTO lesions in the retrograde approach, electrocardiographic R-wave amplitudes often decrease in many leads. Because the differential diagnoses of low voltages on electrocardiogram (ECG) include pericardial effusion, the presence of these changes should increase the index of suspicion for a significant pericardial effusion due to coronary perforation and prompt further evaluation such as echocardiography. Methods: We analyzed the recent 30 patients (group-R, age 65AE12) who underwent successful PCI for CTO lesions in the retrograde approach and the recent 30 patients (group-E, age 60AE10) who underwent treatment for pericardial effusion during catheter intervention. Group-E was divided into 2 groups according to whether requiring drainage of effusion [group-E/D(+) ,n¼15] or not [group E/D(-), n¼15]. Pre-ECG was defined as the ECG just before the catheter intervention. Post-ECG was defined as the ECG just before the procedure of drainage for Group-E/D(+) and the ECG immediately after catheter intervention for other groups. Results: In comparison of pre-ECG and post-ECG, the leads in which R-wave amplitude significantly decreased were I, II, aVL, V1,V4, V5, and V6 in group-R; I, II, aVL,V4, V5, and V6 in group-E/D(+); but only aVL in group-E/D(-). Heart rate (HR) significantly increased in group-E /D(+) (64AE12 to 83AE18, p¼0.0034) between the 2 ECGs, but not in group-R and group-E/D(-). Comparing group-R and group-E/ D(+), the rate of R-wave amplitude between the 2 ECGs [(R-wave amplitude in post-ECG)/(R-wave amplitude in pre-ECG)] was similar in all leads. But the rate of HR between the 2 ECGs [(HR in post-ECG) / (HR in pre-ECG)] was higher in group-E/ D(+) (0.96AE0.34 vs 1.32AE0.29, p¼0.0024). Comparing group-R and group-E/D(-), the rate of HR between the 2 ECGs was similar. But the rate of R-wave amplitudes between the 2 ECGs of group-R was significantly lower in leads I(0.66AE0.25 vs 0.99AE0.58, p¼0.0074), II(0.88AE0.33 vs 1.20AE0.41, p¼0.014), V1(0.72AE0.29 vs 1.11AE0.55, p¼0.0019), and V5(0.67AE0.31 vs 0.95AE0.30, p¼0.0042). Conclusions: During the procedure of PCI for CTO lesions in the retrograde approach, ECG shows decreasing R-wave amplitudes similarly with the case of pericardial effusion requiring drainage during catheter intervention. However, by taking HR into account, decreasing R-wave amplitude during PCI for CTO lesions in the retrograde approach could be discriminated from ECG changes due to pericardial effusion during catheter intervention.
TCT-374
Results of the ALSTER CTO-OCT registry: Delayed DES endothelialization after subintimal recanalization of chronic of total occlusion: Observation by optical coherence tomography Background: Second-generation drug-eluting stents (DES) have reduced the occurrence of target vessel revascularisation (TVR) and stent thrombosis compared to first-generation DES but the clinical impact in chronic total occlusion (CTO) is poorly described. We aimed to compare long-term outcome after 1st and 2nd-generation DES in patients with CTO. Methods: Of 1,343 consecutive Patients who underwent PCI for CTO between 2004 and 2012, long term outcome was evaluated after successful DES implantation. Major adverse cardiac events (MACE) including cardiac death, target vessel revascularisation (TVR) and myocardial infarction (MI) were compared between patients treated with 1st (sirolimus and paclitaxel) and 2nd -generation DES (everolimus, zotarolimus and biolimus). Results: Procedural success was achieved in 1000 (74.4 %) patients of which 943 (70.2%) received at least one stent. DES were implanted in 873 patients (65%) who defined the study population.Patients treated with 1st generation DES (583 patients, 66.9% of the whole population) had a higher rate of current smoking (28% vs. 20% p¼0.007), were more frequently treated for left anterior descending CTO (37% vs. 29% p¼0.018) and had shorter stent length (46 AE 25 vs. 51 AE 25 mm, p¼) compared to patients treated by 2nd generation DES. Age, gender, diabetes, and LVEF were similar between groups. Median follow-up was at 4.1 years (IQR: 2.4-6.5 years). Patients treated 2nd generation DES had lower MACE rate compared to 1st-generation DES (12.7% vs. 21.3%, respectively, p¼0.003). The decrease in MACE rate was driven by lower TVR (8.7%, vs. 13.4%, respectively p¼0.04) whereas cardiac death and MI were similar between groups (p¼0.32 and p¼0.15, respectively). Cumulative event rates by Kaplan-Meier analysis showed lower incidence of TVR among patients treated by 2nd generation stent (p Log Rank ¼0.02). Conclusions: In patients successfully treated by PCI for CTO, 2nd generation DES are associated with better long-term clinical outcome, when compared to 1st generation DES. This is mainly driven by lower TVR rates Background: PCI of chronic total occlusion (CTO) has become more and more aggressive during the last decade, especially because of frequent use of hydrophilic, hard and stiff wires, which have increased the rate of success. Indeed, the incidence and clinical consequences of cardiac tamponade in contemporary practice remain relatively unknown.
Methods: Between October 2003 and June 2010, a total of 1509 consecutive patients were treated by PCI for a CTO defined as the presence of TIMI 0 flow within an occluded arterial segment of greater than 3 months standing. The population characteristics were compared regarding the presence of per and post-procedural tamponade. Results: A cardiac tamponade occurred in 18/1509 patients (1.2%). As opposed to patients with a tamponade-free procedure, patients who have experienced cardiac tamponade were older (68.6AE10.34 vs. 63.4AE11.29, p¼0.03) and had similar risk factors (diabetes in 27% and dyslipidemia in 64%). Cardiac tamponade occurred more frequently in experienced operators reflecting more complex procedures. Absence of visible stump was associated with higher rate of cardiac tamponade (50% vs. 24.8% for patients without tamponade, p¼0.02). There were no differences regarding other angiographic characteristics between the two groups (calcifications, proximal tortuosities, lesion length). The use of a tornus device and a retrograde approach were associated with higher rates of cardiac tamponade (0.17vs 0.02 p¼0.01, and 0.28vs 0.01 p¼0.02, respectively). Procedural duration was longer in patients in whom a cardiac tamponade occurred (124AE24 minutes, vs. 92AE37 minutes, p¼0.01) and success rate was equal (0.77 vs 0.70., p¼0.61, respectively). Importantly, in-hospital stay was longer (7.2AE3.6, vs. 3.1AE3, p<0.0001, respectively) , and rate of in-hospital death was higher among patients who have experienced cardiac tamponade compared to those without per and post-procedural tamponade (11% vs. 1%, p¼0.01, respectively). Conclusions: Cardiac tamponade occurred in 1.2% of a broad population of consecutive patients treated by PCI for chronic total coronary occlusion. Absence of visible stump and use of aggressive devices and strategies were more frequently associate. Background: Percutaneous recanalization of chronic total coronary occlusions (CTO) tends to show a positive effect on LV remodeling and ejection fraction (EF). Nevertheless, its effects on global cardiac functions are yet to be fully understood. Myocardial performance index (MPI) is likely to be more effective for analysis of global cardiac dysfunction than systolic and diastolic measures alone. The aim of this study was to evaluate the effects of recanalization of CTO on global cardiac functions by using MPI. Methods: We evaluated 25 patients (20 men, mean age 57.5AE14.1 years) who had ischemia on myocardial perfusion imaging and underwent successful percutaneous coronary intervention of right coronary artery (RCA) CTO. All patients underwent transthoracic echocardiography before (basal), 24 hours after (early) and at third months (late) of successful PCI. The MPI was calculated by using pulse wave tissue Doppler (TD) echocardiography. Results: There was no difference between basal, early and late left ventricular ejection fraction values (53.5AE10.2, 53.3AE9.5, 53.3AE11.2, respectively). The MPI at third month was significantly increased compared to the basal and early MPI (0.61AE0.09 vs. 0.53AE0.07; p <0.001 and 0.60AE0.08 vs. 0.53AE0.07; p<0.001, respectively). On the other hand, there was no significant difference between basal and early MPI (0.61AE0.09 vs. 0.60AE0.08; p¼0.84, respectively). Also, TD MPI within 3 months was significantly increased when compared to others (0.58AE0.9 vs. 0.53AE0.8; p¼0.003, 0.57AE0.07 vs. 0.53AE0.8; p<0.001, respectively for TD MPI septal and 0.59AE0.08 vs. 0.51AE0.07; p<0.001, 0.58AE0.08 vs. 0.51AE0.07; p<0.001, respectively for TD MPI lateral).
Conclusions:
In this study, we have shown that successful recanalization of CTO results in increased MPI-indicated global cardiac functions within 3 months, while the EF values remain unchanged.
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Drug eluting stents with bioresorbable polymer -short and long term clinical outcomes in the treatment of CTO lesions 
